Ophthalmic Drug Delivery for Noninvasive Neuromodulation in a Mouse Model

0 views • 2:37 min • August 29th, 2025

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Start with a genetically modified mouse whose hippocampal neurons express designer receptors exclusively activated by designer drugs or DREADDs.

These engineered receptors selectively respond to synthetic test drugs while remaining unresponsive to endogenous molecules.

Scruff the mouse regularly to minimize stress and acclimate it to the procedure.

Next, weigh the mouse to calculate the correct drug dosage.

During mouse handling, use a dim red light to prevent circadian disruption.

Gently scruff the mouse to immobilize it.

Using a pipette, take the test drug solution and form a droplet at the tip. Now, approach the eye

and release the droplet onto its surface.

Return the mouse to its home cage. Repeat the drug delivery several times.

The drug absorbs through the eye and enters the brain.

It then crosses the blood-brain barrier and reaches the hippocampal region. Later, it binds to DREADD receptors and activates neurons, enabling precise, noninvasive neuromodulation.

For repetitive CNO delivery, beginning four weeks post injection, acclimate the animals to handling by scruffing each mouse three minutes daily for three to four days prior to the administration of the eyedrops. When the mice have become acclimated to handling, weigh each mouse to determine the appropriate amount of CNO to be delivered to achieve a one milligram of CNO per kilogram of body weight concentration.

Two hours before lights off during the inactive phase, load one to three microliters of the prepared CNO solution into a P10 micropipette and immobilize the mouse via scruffing. Slowly expel the solution until a stable droplet forms on the pipette tip and carefully bring the droplet close to the cornea until the solution is delivered without touching the pipette tip to the mouse's eye. Then return the mouse to its home cage before applying the CNO eyedrop to the eye of the next animal.

In cases where CNO needs to be delivered during the mouse active phase, ensure the presence of a dim red light for proper animal handling and CNO delivery.

10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Related Videos

0 Views

10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Related Videos

0 Views

08:37

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Related Videos

0 Views

07:15

Intranasal Administration of CNS Therapeutics to Awake Mice

Related Videos

0 Views

03:24

Intracerebroventricular Injection in Mouse: An Ommaya Mediated Direct Drug Administration Method to Deliver Drugs to Cerebral Ventricles of Mouse Brain

Related Videos

0 Views

02:24

Osmotic Pump-Based Neurotherapeutic Drug Delivery in a Demyelinated Mouse Model

Related Videos

0 Views

07:34

Minimally-invasive Technique for Injection into Rat Optic Nerve

Related Videos

0 Views

09:26

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Related Videos

0 Views

08:28

Non-invasive Strategies for Chronic Manipulation of DREADD-controlled Neuronal Activity

Related Videos

0 Views

07:12

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Related Videos

0 Views

Last updated: 27 June 2026